MD3041G2 - Method of mamma dishormonal dysplasia prophylaxis - Google Patents

Method of mamma dishormonal dysplasia prophylaxis Download PDF

Info

Publication number
MD3041G2
MD3041G2 MDA20050300A MD20050300A MD3041G2 MD 3041 G2 MD3041 G2 MD 3041G2 MD A20050300 A MDA20050300 A MD A20050300A MD 20050300 A MD20050300 A MD 20050300A MD 3041 G2 MD3041 G2 MD 3041G2
Authority
MD
Moldova
Prior art keywords
prophylaxis
dishormonal
mamma
dysplasia
administered
Prior art date
Application number
MDA20050300A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD3041F1 (en
Inventor
Ион МЕРЕУЦЭ
Владимир КАРАУШ
Люба МУНТЯНУ
Original Assignee
Ион МЕРЕУЦЭ
Владимир КАРАУШ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ион МЕРЕУЦЭ, Владимир КАРАУШ filed Critical Ион МЕРЕУЦЭ
Priority to MDA20050300A priority Critical patent/MD3041G2/en
Publication of MD3041F1 publication Critical patent/MD3041F1/en
Publication of MD3041G2 publication Critical patent/MD3041G2/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention refers to medicine, in particular to mammology and may be used for prophylaxis of dyshormonal hyperplasiae to patients with associated gynecologic and nongynecologic diseases.Summary of the invention consists in that it is administered a preparation containing motherwort tincture (1:5), valerian tincture (1:5), 30% oleic tocopherol solution, alcoholic linseed extract, alcoholic extract of nut kernel and internal septa and 70% ethyl alcohol in the following component ratio, mass %:which is administered for 10…15 drops of preparation 3 times a day before meals, during 3 weeks.
MDA20050300A 2005-10-07 2005-10-07 Method of mamma dishormonal dysplasia prophylaxis MD3041G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20050300A MD3041G2 (en) 2005-10-07 2005-10-07 Method of mamma dishormonal dysplasia prophylaxis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20050300A MD3041G2 (en) 2005-10-07 2005-10-07 Method of mamma dishormonal dysplasia prophylaxis

Publications (2)

Publication Number Publication Date
MD3041F1 MD3041F1 (en) 2006-05-31
MD3041G2 true MD3041G2 (en) 2006-12-31

Family

ID=36497641

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20050300A MD3041G2 (en) 2005-10-07 2005-10-07 Method of mamma dishormonal dysplasia prophylaxis

Country Status (1)

Country Link
MD (1) MD3041G2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD65Z (en) * 2009-04-23 2010-03-31 Виталие МАКИДОН Noninvasive method for treating mammary fibroadenoma
MD411Z5 (en) * 2010-10-21 2012-03-31 Институт Сельскохозяйственной Техники "Mecagro" Installation for continuous metering of liquid (variants)
CN107715036A (en) * 2017-10-26 2018-02-23 闫秋菊 A kind of medicine for treating the proliferation of mammary gland

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1142925A1 (en) * 1981-10-28 1989-10-30 Научно-Исследовательский Институт Рентгенологии, Радиологии И Онкологии Method of treating intraduct tumors of mammary gland
SU1711922A1 (en) * 1985-05-15 1992-02-15 Московский Научно-Исследовательский Рентгенорадиологический Институт Method for treating mammary adenocarcinoma
MD2827G2 (en) * 2005-03-04 2006-04-30 Михаил СУРГУЧ method of prophylaxis of the dishormonal mammary hyperplasiae

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1142925A1 (en) * 1981-10-28 1989-10-30 Научно-Исследовательский Институт Рентгенологии, Радиологии И Онкологии Method of treating intraduct tumors of mammary gland
SU1711922A1 (en) * 1985-05-15 1992-02-15 Московский Научно-Исследовательский Рентгенорадиологический Институт Method for treating mammary adenocarcinoma
MD2827G2 (en) * 2005-03-04 2006-04-30 Михаил СУРГУЧ method of prophylaxis of the dishormonal mammary hyperplasiae

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD65Z (en) * 2009-04-23 2010-03-31 Виталие МАКИДОН Noninvasive method for treating mammary fibroadenoma
MD411Z5 (en) * 2010-10-21 2012-03-31 Институт Сельскохозяйственной Техники "Mecagro" Installation for continuous metering of liquid (variants)
CN107715036A (en) * 2017-10-26 2018-02-23 闫秋菊 A kind of medicine for treating the proliferation of mammary gland

Also Published As

Publication number Publication date
MD3041F1 (en) 2006-05-31

Similar Documents

Publication Publication Date Title
Ivanova Stojcheva et al. The effectiveness of rhodiola rosea L. Preparations in alleviating various aspects of life-stress symptoms and stress-induced conditions—encouraging clinical evidence
Sun et al. Efficacy of multivitamin supplementation containing vitamins B6 and B12 and folic acid as adjunctive treatment with a cholinesterase inhibitor in Alzheimer's disease: a 26-week, randomized, double-blind, placebo-controlled study in Taiwanese patients
Brown et al. Rhodiola rosea
RU2010105123A (en) COMPOSITIONS FOR CARE OF THE ORAL CAVITY, PRODUCTS AND METHODS OF APPLICATION
AR053680A1 (en) COMPOSITION
NO20070887L (en) Granular pharmaceutical formulation with time-limited release for oral administration, and intraoral rapid disintegrating tablet containing the preparation
BRPI0510430A (en) compositions and methods for mucosal vaccination
Sahoo et al. Aphrodisiac activity of polyherbal formulation in experimental models on male rats
RU2010106225A (en) COMPOSITION AND METHOD USING A STABILIZED SENSITIVE INGREDIENT
Sulaeman et al. Trigona propolis and its potency for health and healing process
Park et al. The effects of Astragalus membranaceus on repeated restraint stress-induced biochemical and behavioral responses
WO2007107787A3 (en) Liquid and solid dosage formulations containing date fruit (phoenix dactylifera)
MD3041G2 (en) Method of mamma dishormonal dysplasia prophylaxis
BRPI0712478B8 (en) use of plant material or plant material extract
Neve et al. Evaluation of anti-inflammatory and analgesic property of methanolic extract of momordica dioica in wistar rat model
EP2043668B1 (en) Use of echinacea or preparations thereof in compositions for the treatment of anxiety
US9060989B2 (en) Method for treating or relieving inflammatory bowel disease
SM et al. Evaluation of hypoglycemic effect of Lagerstroemia speciosa (banaba) leaf extract in alloxan induced diabetic rabbits
Ahmed Effect of Mixture of Chia, Flax and Milk thistle Seeds on Carbon Tetrachloride (CCl4) Induced Hepatotoxicity in Female Albino Rats.
NO20056042L (en) Compounds useful in the treatment of Alzheimer's disease as well as formulations containing them
WO2007145993A3 (en) Modified compositions and methods for enhancing brain function
JP2014224083A (en) Sexual function enhancement composition
Muskin et al. Complementary and Integrative therapies for psychiatric disorders, an issue of psychiatric clinics
MD3121G2 (en) Method of viral hepatitis B prophylaxis
WO2007071205A3 (en) A taxane derivative containing pharmaceutical composition with improved therapeutic efficacy

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees